IDO1 and hereditary clear cell renal cell carcinoma: By following a ‘reverse immunology’ approach, we identified HLA-A2 peptides within the IDO protein to which spontaneous T-cell reactivity were detected in patients suffering from unrelated tumor types, i.e. melanoma, renal cell carcinoma and breast cancer but not in healthy individuals.